AbCellera Biologics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
18.83 | 48.77 | -61.4% | 29 | -35.07% |
| P/S |
|
43.88 | 33.76 | 29.98% |
|
|
| P/BV |
|
1.45 | 4.82 | -69.96% |
|
|
| P/FCF |
|
-13.1 | 61 | -121.47% |
|
|
| Ev/Ebitda |
|
-8.39 | -22.15 | -62.12% |
|
|
| Ev/S |
|
42.41 | 22.56 | 87.94% |
|
|
| Ev/FCF |
|
-13.28 | 68.78 | -119.32% |
|
|
| E/P |
|
-0.0921 | 0.0178 | -618.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-505.35 | 4.98 | -10253.76% | -76.13 | +563.79% |
| ROE |
|
-12.7 | 9.61 | -232.18% |
|
|
| ROA |
|
-9.84 | 0.3443 | -2957.71% |
|
|
| ROIC |
|
18.42 | 7.63 | 141.28% |
|
|
| ROS |
|
-385 | -25.17 | 1429.59% |
|
|
| ROCE |
|
-19.36 | 15.35 | -226.1% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4027 | -3.68 | -89.04% | -5.68 | -92.91% |
| Nеt Debt/Ebitda |
|
0.2911 | -3.44 | -108.47% |
|
|
| Debt/Ratio |
|
0.052 | 0.1985 | -73.8% |
|
|
| Debt/Equity |
|
0.3561 | 1.66 | -78.58% |
|
|
| Debt/Net Income |
|
-0.5286 | 10.32 | -105.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
227.8 | -56.89 | -500.42% | ||
| Growth impulse Ebitda in 5 years |
|
56251.32 | -54.68 | -102973.66% | ||
| Growth impulse Net Income in 5 years |
|
7219.9 | -58.33 | -12477.68% | ||
| Growth impulse FCF in 5 years |
|
9237.23 | -49.48 | -18768.61% | ||
| Growth impulse EPS in 5 years |
|
5856.19 | -32.41 | -18169.08% |
IP Score
5.13/10
